 |
 |
 |
 |
 |
 |
 |
 |
E-Mail
ShareAntiretrovirals in Development
Overview
- In Lab Experiment, Two Cancer Drugs Successfully Stop HIV (August 25, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation - An Anti-Inflammatory Antiretroviral? CCR5/CCR2 Antagonist TBR-652 Monotherapy Study Results: A Blog Entry by Myles Helfand (July 19, 2010)
In The XVIII International AIDS Conference, from The Body PRO - CROI 2010 Wrap-Up: The HIV Drug Development Pipeline (March 8, 2010)
A discussion with Joel Gallant, M.D., M.P.H.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - The Once and Future King: What Will Replace Atripla Atop the First-Line HIV Treatment Realm? (Feb. 19, 2010; 3:39 p.m. Pacific Time)
A blog entry from CROI 2010 by Gerald Pierone Jr., M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - ViiV Vows Joint Venture Will Help Fight HIV (November 10, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - GlaxoSmithKline, Pfizer Formally Launch Company to Develop New HIV Treatments (November 3, 2009)
Two of the major pharmaceutical companies producing antiretrovirals have launched a new joint company focused solely on HIV: ViiV Healthcare.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation - Drug Watch: Two New Pharmacoenhancers Give HAART a Boost (Summer/Fall 2009)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - HIV Antiretrovirals in Development: An Update From ICAAC 2009 (October 22, 2009)
In The 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - Immune Therapies in Development (September 24, 2009)
To read PDF, click here.
From AIDS InfoNet - Vicriviroc Safe and Effective in Treatment-Experienced HIV-Infected Patients at 96 Weeks (September 13, 2009)
An interview with Lisa Dunkle, M.D.
In The 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - Small Clinical Trial Examines Drug's Ability to Reduce HIV in Body (July 22, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Antiretroviral Drug Development in 2009 (July 2009)
To read PDF, click here.
In TAG 2009 Pipeline Report, from Treatment Action Group - Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV (April 17, 2009)
Study will assess safety and efficacy of single-tablet regimen containing elvitegravir boosted by GS 9350 and Truvada compared to Atripla.
From Gilead Sciences, Inc. - HIV Drugs in the Pipeline (March/April 2009)
[Archived Article]
A concise summary of drugs further along in development.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network - New Pharmaco-Enhancers (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Combining New Drugs (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - The Coming Crisis (October 2008)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis - The Coming Crisis in HIV Drug Development (June 16, 2008)
From Project Inform - Novel HIV Therapy Suffers Stunning Setback (June 12, 2008)
From Project Inform - Compound Has Potential for New Class of AIDS Drugs (May 14, 2008)
From University of Michigan - Update From CROI 2008 on Experimental Drugs (April 2008)
To read PDF, click here.
In Project Inform Perspective, from Project Inform - Update on New Antiretroviral Drugs (November/December 2007)
An interview with Harold Kessler, M.D.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network - 2007 Antiretrovirals in Development Pipeline (March 23, 2007)
From Treatment Action Group - HIV Antiretroviral Agents in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body PRO - Oral Abstracts and Research Overview: Antiretroviral Therapy I: New Agents and New Insights (MP3) (February 6, 2006)
Podcast of presentations from CROI 2006; also available as an audio Webcast and a video Webcast.
From 13th Conference on Retroviruses and Opportunistic Infections - Pipeline Progress -- Then and Now (Summer 2005)
[Archived Article]
Much has changed in HIV drug development since 2002.
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Update on Salvage Therapy for HIV-Infected Patients (February 25, 2005)
[Archived Article]
A detailed review of recent research related to the treatment of patients with multi-drug resistance, including an examination of developing drugs.
To read PDF, click here.
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Plotting the Perfect Protease Inhibitor (January/February 2005)
[Archived Article]
A session recap from the 12th Conference on Retroviruses and Opportunistic Infections.
In GMHC Treatment Issues, from Gay Men's Health Crisis - News on Developing Drugs and Drug Interactions (September/October 2004)
[Archived Article]
Updates on tipranavir, GS 9005 and the interaction between ddI and tenofovir.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Anti-HIV Therapy Update (July 2004)
[Archived Article]
A quick briefing on tipranavir, TMC-114, capravirine and D-D4FC.
To read PDF, click here.
In Project Inform Perspective, from Project Inform - New Drug Delivery Strategies (July 2004)
[Archived Article]
Patches, gels and inhalers: A look at what the future may hold in store for antiretroviral drug delivery.
To read PDF, click here.
In Project Inform Perspective, from Project Inform - Drug Development News: Boehringer Ingelheim (May/June 2004)
[Archived Article]
An update on the protease inhibitor tipranavir and the NRTI alovudine, both for treatment-experienced patients.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Where's My Pipeline? Vicissitudes of Medicine and Marketing Take Toll on Me-Too Lineup (April 2004)
[Archived Article]
In TAGline, from Treatment Action Group - Seven (Minus 4, Plus 3) Agents to Fix Your Gaze On (March 2004)
[Archived Article]
A farewell look at some of last year's failed antiretrovirals, and a quick look at some of this year's most promising new drugs.
In TAGline, from Treatment Action Group - New Antiretroviral Drugs in Development (February 11, 2004)
[Archived Article]
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - New Targets, New Drugs, Failed Trials and the Need for More Information (January/February 2004)
[Archived Article]
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network - Taking Giant Steps Forward in Antiviral Drug Treatment (January/February 2004)
[Archived Article]
A look at the medications and strategies that comprise HIV treatment today -- and may comprise it tomorrow.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network - Summer HIV Drug Pipeline Update (July 2003)
[Archived Article]
In TAGline, from Treatment Action Group - A Different Class: New HIV Therapies on the Horizon (May/June 2003)
[Archived Article]
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network - Notes on HIV Drugs in Development (May 2003)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis - An Interview With Dr. Cal Cohen on Highlights From the 10th Conference on Retroviruses and Opportunistic Infections (April 4, 2003)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News - And More, and More ... (April 2003)
[Archived Article]
A summary of study results regarding a range of lesser-known developing antiretrovirals from CROI 2003.
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - What's So Special About the New Antiretrovirals? (April 2003)
[Archived Article]
A chart summarizing key points and recent study results.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - View From the Pipeline: The 2003 Review of Experimental Antiretrovirals (March 13, 2003)
[Archived Article]
An overview of research presented at the 2003 Retrovirus conference.
In The PRN Notebook - CROI 2003: Emerging HIV Therapies (February 14, 2003)
[Archived Article]
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - In-Vitro Characterization of Novel Benzophenone NNRTIs (February 11, 2003)
[Archived Article]
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - New Hope From New Classes of Therapy (January 2003)
[Archived Article]
Recaps of entry and integrase inhibitor research from Barcelona.
To read PDF, click here.
In Project Inform Perspective, from Project Inform - New Anti-HIV Therapies (January 2003)
[Archived Article]
To read PDF, click here.
From Project Inform - Anti-HIV Candidates in the Pipeline (Winter 2002/2003)
[Archived Article]
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America - New and Improved? Next Generation Drugs in Existing Classes (Winter 2002/2003)
[Archived Article]
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America - New Drugs and Reformulations Closest to Approval (Summer/Autumn 2002)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - The Future of HIV Treatment: I Left My HAART in the 20th Century (July 2001)
Charles Flexner, M.D., ruminates on the future of HIV treatment.
In Hopkins HIV Report
The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.